Faecal pancreatic elastase testing can now be automated, providing flexible and random-access application on most clinical chemistry platforms. The new fPELA turbo from BÜHLMANN is ideal for identification and monitoring of pancreatic insufficiency.
There is the added advantage that it utilises the same CALEX extraction device as the fCAL turbo assay, so it is possible to run both tests from a single extract.
The fPELA technology is a milestone in automation of pancreatic elastase quantification. It reduces the hands-on time dramatically and allows reporting of pancreatic elastase results from human stool samples within the shortest time. Time to first result is just 10 minutes, with further results following every few seconds thereafter, making it one of the fastest faecal elastase assays available.
Tel: 0800 38 77 32
Email: [email protected]